secwatch.observer — SEC 8-K summary
======================================

Issuer:     Chemours Co (CC)
CIK:        0001627223
Form:       8-K
Filed at:   2024-02-13T23:59:59+00:00
Accession:  0000950170-24-014589
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemours reschedules Q4/FY 2023 earnings; cites internal control evaluation and Audit Committee review
--------------------------------------------------------------------------------

- Earnings release postponed from Feb 14 to Feb 28, 2024; conference call moved to Feb 29.
- Company needs extra time to complete year-end reporting; evaluating internal controls over financial reporting.
- Audit Committee conducting an internal review related to information and communications.
- Annual Report on Form 10-K expected to be filed by Feb 29, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1627223/000095017024014589/0000950170-24-014589-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1627223/000095017024014589/cc-20240213.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-014589

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer